NIPTs Pose Moral Quandaries | GenomeWeb

As non-invasive prenatal genetic testing advances more broadly into the marketplace and as tests for more and more disorders, conditions — and eventually, traits — become widely available to pregnant women and couples, some difficult ethical questions are bound to arise, Amanda Schaffer writes at Technology Review.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.